Pharmacotherapeutics for Advanced Practice 5th Edition – Arcangelo | Complete Test Bank

'(

&)*+)& &
)*+)&,-./&'01&23-14-50)3*1-2*()
5+&'01&
-67-.5*6&21-5)
5*&-&21-5)
5-
&-2210-53&$)3&
*6
)
0.&,8&7
19
.
-&200
*&-15-.9*
0:&-.61*;&
2*)*1+0.:&7*10.
5-&;

,(1:&<*..
'*1&-=&1*
.30
6&
>?@ABCD>DE@F?@G@AHID@?CJBIKE?FLBMC>NOI@PMC?@QFFR
SC?@E@CDHAPTC?PUDFTAIFHD@LLCD@HBCIKHEBC?BMCF?DC?




























!"#$

%& 


VW
XW

Y25Z[696
7689 
[[
Y\Z963836
][6
0 12352367689 87658 52362998

,012346786949




 ! "# 
$ ! $!%
&!

$'$()(

*% ! $+
+$, 
- ! %.%$'$%
/%'!0%

1 ! 
!
2
)! ! 
3 ! 4 
!
54 
!.$6
$7.6
8
99 0$4 
!
9
! 
9&:
%+;%+$# %<"
9*
-';%
$=
9/. %!
$
1.4$$.)>
2?
3?%$!
5 <0%'
$4$%
?:%
 '!
&=
*'! $ .0(%!

-@ +:%+$%!! #A%
$
/@ 
%=%>
$6%

1,(

26

3
$$)%

&5.((#%$$
&<>%%
!$
&.$@
&&.
&*= ! $'
&-?$
&/<B
$
&1'%B!C

&2"C

&34 D
(
$$#%
$
*5'>
$
*9<%
$
*'
?(
$
*&<06
$
**
04%%
*-
$$$
$

,012345689 56 52 56 524
012345682556
01234568

62
6232424
01234568
16 5  !656
0123456"#5 2
0123456"$24
0123456"%&'0524
0123456"()5 14*
0123456"80462534
0123456""+5325
0123456"92 4

,  012345789  







012345789  

































!"##$#$%
&'(














)*+'
!+,-.
,
/01234563789:9:;<53635483:69:=5729>;3:9?:435@2A795BC?D
E0F>5179:;<7AG;2<8:A;HI9795J;73B4;H1234:<@
J0F>5K0I0L32@M<H;385N5<9EBN:<:49379:;<
G0F>5I9795J;73B;H1234:<@H;3578>49795
L0F>5I9795J;73B;HO>73N78?
E1IDG OFID/
P0O>?4:8:7<E44:497<9QOER635483:69:=5729>;3:9?:435@2A795BC?D
E0F>5179:;<7AG;2<8:A;HI9795J;73B4;H1234:<@
J0F>5K0I0L32@M<H;385N5<9EBN:<:49379:;<
G0F>5I9795J;73B;H1234:<@
L0F>5I9795J;73B;HS5B:87AMT7N:<534
E1IDL OFID/
U0GA:<:87AV2B@N5<9:<635483:C:<@:<8A2B54D
E0W789;3:<@:<9>58;499;9>5679:5<9;H9>5N5B:879:;<635483:C5B
J0EAX7?4635483:C:<@9>5<5X549N5B:879:;<7=7:A7CA5H;39>5B:4574563;8544
G0Y7<B:<@;29B32@47N6A549;6;;3679:5<94
L0O35483:C:<@7AA@5<53:8N5B:879:;<49;8298;494
E1IDE OFID/
Z0G3:953:7H;38>;;4:<@7<5HH589:=5B32@H;37B:4;3B53:<8A2B5D
E0E4[:<@9>5679:5<9X>79B32@9>5?9>:<[X;2ABX;3[C549H;39>5N
J0G;<42A9:<@<79:;<7AA?358;@<:\5B@2:B5A:<54H;3B:45745N7<7@5N5<9
G0O35483:C:<@N5B:879:;<49>797357=7:A7CA57447N6A54C5H;35X3:9:<@7635483:69:;<
L0W;AA;X:<@K0I0L32@M<H;385N5<9EBN:<:49379:;<QLMER@2:B5A:<54H;3
635483:C:<@
E1IDJ OFID/
]01234563789:9:;<5363789:85N7?9>3:=52<B53>57A9>^873535H;3NB259;D
E0F>5B5N;<493795B7C:A:9?;H<234563789:9:;<5349;8;<93;A8;4947<B:N63;=5679:5<9
;298;N54
J0F>5H7899>79<234563789:9:;<534X:AAC57CA59;63789:85:<B565<B5<9A?
G0F>5H7899>79<234563789:9:;<534X:AA>7=5H2AA35:NC2345N5<92<B53>57A9>^8735
35H;3N
L0F>57C:A:9?9;4>:H9788;2<97C:A:9?H;3S5B:87:B9;9>549795A5=5A
E1IDE OFID/